Rather than just medication alone, it focuses on sustainable, long-term results through structured education, regular check-ins, and ongoing accountability
FDA GLP-1 approval to reduce cardiovascular risk in obesity World Health Organization 2025 guideline on GLP-1 medicines for obesity NIH / PubMed cardiovascular and kidney outcomes of GLP-1 in older adults The Lancet eClinicalMedicine GLP-1 use and lower dementia risk in older adults The BMJ gastrointestinal side effects of GLP-1 medications The Lancet Healthy Longevity GLP-1 and sarcopenia risk in frail older adults NIH / PubMed dehydration and GLP-1 therapy ScienceDirect long-term safety considerations for GLP-1 use ScienceDirect monitoring guidance for GLP-1 medications MDWatch Weight-Loss Program See if a GLP-1 is right for you Get a personalized plan from board-certified medical providers who treat seniors every day
If you lost 35 pounds in the first six months, you might lose an additional 15 to 25 pounds in the second six months
In the COR-II trial published in 2013, researchers studied the weight loss effects of Contrave for people struggling with obesity (2)
The healthcare BPO team manages the full patient communication stack around prescription workflows: inbound support for refill inquiries, insurance verification assistance, back-office documentation, pharmacy coordination support, and proactive patient outreach for upcoming refills